Cargando…
Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer
DC Bead(®) is a drug delivery embolisation system that can be loaded with doxorubicin or irinotecan for the treatment of a variety of liver cancers. In this study we demonstrate that the topoisomerase I inhibitor topotecan hydrochloride can be successfully loaded into the DC Bead sulfonate-modified...
Autores principales: | Forster, Richard E. J., Small, Sharon A., Tang, Yiqing, Heaysman, Clare L., Lloyd, Andrew W., Macfarlane, Wendy, Phillips, Gary J., Antonijevic, Milan D., Lewis, Andrew L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935541/ https://www.ncbi.nlm.nih.gov/pubmed/20563626 http://dx.doi.org/10.1007/s10856-010-4107-4 |
Ejemplares similares
-
Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment
por: Boatta, Emanuele, et al.
Publicado: (2013) -
Drug eluting beads on cytology smears
por: Manglik, Niti, et al.
Publicado: (2012) -
Drug-eluting beads in hepatocellular carcinoma
por: Abe, Hiroyuki, et al.
Publicado: (2017) -
Synthesis and characterisation of cationic quaternary ammonium-modified polyvinyl alcohol hydrogel beads as a drug delivery embolisation system
por: Heaysman, Clare L., et al.
Publicado: (2016) -
DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy
por: Lewis, Andrew L., et al.
Publicado: (2015)